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Background: Epilepsy is the most common neurological problem that affects people with learning disabilities. The
high seizure frequency, resistance to treatments, associated skills deficit and co-morbidities make the management
of epilepsy particularly challenging for people with learning disabilities. The Books Beyond Words booklet for
epilepsy uses images to help people with learning disabilities manage their condition and improve quality of life.
Our aim is to conduct a randomized controlled feasibility trial exploring key methodological, design and
acceptability issues, in order to subsequently undertake a large-scale randomized controlled trial of the Books
Beyond Words booklet for epilepsy.
Methods/Design: We will use a two-arm, single-centre randomized controlled feasibility design, over a 20-month
period, across five epilepsy clinics in Hertfordshire, United Kingdom. We will recruit 40 eligible adults with learning
disabilities and a confirmed diagnosis of epilepsy and will randomize them to use either the Books Beyond Words
booklet plus usual care (intervention group) or to receive routine information and services (control group). We will
collect quantitative data about the number of eligible participants, number of recruited participants, demographic
data, discontinuation rates, variability of the primary outcome measure (quality of life: Epilepsy and Learning
Disabilities Quality of Life scale), seizure severity, seizure control, intervention’s patterns of use, use of other
epilepsy-related information, resource use and the EQ-5D-5L health questionnaire. We will also gather qualitative
data about the feasibility and acceptability of the study procedures and the Books Beyond Words booklet. Ethical
approval for this study was granted on 28 April 2014, by the Wales Research Ethics Committee 5. Recruitment
began on 1 July 2014.
Discussion: The outcomes of this feasibility study will be used to inform the design and methodology of a
definitive study, adequately powered to determine the impact of the Books Beyond Words intervention to improve
the management of epilepsy in people with learning disabilities.
Trial registration: ISRCTN80067039 (Date of ISRCTN assignation: 23 April 2014).
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Rationale
People with learning disabilities experience a dispropor-
tionate burden of ill health and are affected by twice the
number of health issues prevailing in the general po-
pulation: higher incidence of long-term conditions and
health risks, poorer health outcomes and an increased
risk of premature death [1-4]. Epilepsy is one of many
long-term conditions affecting people with learning dis-
abilities that burdens their lives and hinders their quality
of life [5]. It is considered the most common neuro-
logical disorder in people with learning disabilities, with
a reported prevalence of 16 to 44% [2,5-8], compared to
0.4% to 1% in the general population [9,10].
The clinical management of epilepsy in people with
learning disabilities is complex, due to both the clinical
characteristics of the condition, as well as physical and
cognitive impairments affecting them. Seizures are fre-
quent, atypical and often severe. Approximately 70% of
all seizures are refractory to treatment [11-14]. Seizures
are less well controlled than in the general population of
people with epilepsy, and may be accompanied by co-
morbid health, mental health, sensory-motor and com-
munication issues [15-17]. Poorly controlled epilepsy
can severely affect social relationships, work, daily activ-
ities, quality of life and mortality [18-20]. As a result,
young people and adults with learning disabilities and
epilepsy face higher risks of premature and avoidable
death related to epilepsy than the general population
[21]. In addition, research shows that poorly controlled
seizures and seizure frequency are associated with in-
creased costs [22]. Pennington et al. recently demon-
strated increased costs in people with epilepsy and
learning disabilities [23], with a total estimated cost per
patient, per annum, of £64,000 (including accommoda-
tion and basic care).
Managing long-term conditions is challenging for all
patients, irrespective of their abilities and co-morbidities.
However, it is even more complex for those with learn-
ing disabilities, who may not have the knowledge, skills
and support required to assess potential risks and cope
with recurring seizures, prescribed medications and
regular doctor appointments. Research suggests that ac-
cess to specialist services is poor for people with epilepsy
and learning disabilities [24]. For carers and families
who are not trained in supporting self-management, car-
ing for adults with ‘dual disabilities’ can be extremely
challenging and increase the caregiver burden [5]. Des-
pite its high incidence, little is known about the manage-
ment of epilepsy in people with learning disabilities, and
those who support them. Research suggests that people
with learning disabilities and epilepsy lack skills training
adapted to their needs and intellectual abilities, and
often fail to adequately manage and control theirepilepsy [20]. The standard of care offered to people
with learning disabilities and epilepsy is significantly
poorer than in the general population, as is the case
for most disease areas affecting people with learning
disabilities [24,25].
Guidelines from the National Institute for Health and
Care Excellence (NICE) state that patients with epilepsy
and learning disabilities: ‘should be empowered to
manage their condition as well as possible, and should
receive appropriate information and education about all
aspects of epilepsy […] accessible to people with
additional needs such as physical, sensory or learning
disabilities’ [26]; p.9.
The Books Beyond Words booklet Getting on with
Epilepsy has been designed to help people with learn-
ing disabilities and epilepsy understand and manage
their illness through images that have been tested with
people with mild to severe learning disabilities. The
intervention is based on the assumption that people
with learning disabilities who cannot read and have
limited communication abilities are visually literate.
Although the success and impact of the Books Beyond
Words booklets (over 30 available) have been recog-
nized by several awards and collaborations with estab-
lished patient organizations, they have not as yet been
formally evaluated in controlled settings or routinely
adopted in the United Kingdom National Health Service
(NHS). The lack of conclusive data on the effectiveness
of educational interventions for people with epilepsy
and learning disabilities warrants further investigation
[24,26].
Aim
We aim to conduct a randomized controlled feasibility
trial exploring key methodological, design and accept-
ability issues, in order to subsequently undertake a
large-scale randomized controlled trial of the Books
Beyond Words booklet as an intervention for epilepsy in
adults with learning disabilities.
Objectives
Our objectives are to:
1. Assess the feasibility of undertaking a randomized
controlled trial of the Books Beyond Words
intervention for epilepsy in people with learning
disabilities.
2. To explore the feasibility of collecting resource use
and quality of life data so as to inform the design of
the health economics component of a future
definitive trial.
3. Assess the study procedures’ and intervention’s
acceptability among adults with learning disabilities,
carers and health professionals.
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Study design and setting
We will use a two-arm, single-centre design and will con-
duct the study over a 20-month period at Hertfordshire
Partnership University NHS Foundation Trust, United
Kingdom. The trust runs five epilepsy clinics, managing
196 adults with learning disabilities and epilepsy. The pa-
tients are seen on average once a month. We will ran-
domly allocate eligible participants to an intervention
arm (provision of the Books Beyond Words booklet Get-
ting on with Epilepsy) and control arm (routine informa-
tion and services), and will recruit participants over six
months.
Participants
Eligible participants will be identified by the consultant
psychiatrists who run the epilepsy clinics. Each psych-
iatrist will compile a log of potentially eligible patients
from existing records and from new referrals using the
following criteria.
Inclusion criteria
The inclusion criteria for this study are as follows:
1. Male and female patients, over 18 years of age.
2. A confirmed clinical diagnosis of epilepsy (according
to medical notes) and at least one seizure over the
past 12 months.
3. A confirmed clinical diagnosis of a learning disability
(significantly below-average general intellectual
functioning, and an IQ below or equal to 70).
4. Meaningful communication that enables the patient
to tell or follow the Books Beyond Words story, as
judged by the carer and/or health professional.
5. The carer is sufficiently proficient in English to read
and complete the questionnaires with the patient.
Exclusion criteria
The exclusion criteria for this study are as follows:
1. Vision impairment.
2. Confirmed diagnosis of dementia.
3. Have used the Books Beyond Words booklet for
epilepsy in the past 12 months.
Consent
Each consultant psychiatrist at the participating epilepsy
clinics will send an invitation letter and two information
sheets to the carers of all eligible patients with learning
disabilities and epilepsy registered at the clinics. In ac-
cordance with the Mental Capacity Act 2005 [27], an
easy-read information sheet and invitation letter will be
intended for the patient and another information sheet
for the carer. In the information sheet, carers will beasked to encourage patients who have the capacity to
read and understand (or to be read to and understand)
the easy-read information sheet to do so. For patients
who lack the mental capacity to understand the informa-
tion sheet, consent will be obtained from the patient’s
carer. It will be the carer’s role to use what they know of
the patient’s wishes and feelings about research to decide
whether they would like to take part in the study.
After a week, the research nurse will invite carers and
patients by phone, to attend a meeting at the epilepsy
clinic. During this appointment, the research nurse will
review the patient information sheets with both the pa-
tient and the carer, and will take consent from the pa-
tient, with the carer’s involvement and advice, using an
easy-read consent form. For patients who lack the cap-
acity to consent, the research nurse will use a consultee
declaration form, which will be completed and signed by
the carer. The research nurse will also inform the pa-
tient’s GP of their participation in the feasibility trial.
Randomization
During the initial appointment with the research nurse
at the epilepsy clinic, and after consent has been taken,
the carer will complete the baseline questionnaire.
Randomization will be managed by the Norwich Clinical
Trials Unit (NCTU). Once consent is obtained and the
baseline data registered, the research nurse will allocate
the patient to the intervention or control arm, as
instructed by the randomization website. All authorized
users, including the research nurse, will login using their
unique username and password to a secure website to
randomize each participant. The results will be stored in
a study database on the Norwich Clinical Trials Unit
(NCTU) secure server at the University of East Anglia
(no user identifiable data will be stored in the
randomization database). Web traffic will be encrypted
using standard secure sockets layer technology. The
randomization (1:1 allocation ratio) will be ‘blocked’ into
groups of six codes to reduce the imbalance of control
and intervention group participants at any time.
Intervention group
The Books Beyond Words booklet Getting on with Epi-
lepsy uses pictures to tell the story of a young man with
learning disabilities and epilepsy who progressively
learns how to better manage his condition and recurrent
seizures (see Figure 1). The intervention aims to improve
seizure control, reduce the risk of falls and seizure-
related injuries and improve quality of life. It also aims
to illustrate best practice and promote access to relevant
services. The Books Beyond Words booklet for epilepsy
was developed over an 18-month period, by an editorial
team of consultants in psychiatry and neurodevelopmen-
tal psychiatry, a speech and language therapist and an
Sheila Hollins & Lisa Kopper www.booksbeyondwords.co.uk
Figure 1 The Books Beyond Words intervention.
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of medical experts in the field of epilepsy and learn-
ing disabilities, by adults with learning disabilities
and their carers, voluntary organizations and advo-
cacy groups. Several iterations were developed and
tested with a wide group of stakeholders, including
adults with mild to severe learning disabilities and
epilepsy [28].How the Books Beyond Words intervention will be used
After giving consent and completing the baseline ques-
tionnaires, patients in the intervention condition will use
the booklet with the research nurse and carer, in a quiet
room at the epilepsy clinic. The nurse will go through
the booklet with each patient at their own pace. Health
professionals and carers can create their own story with
the patient or use the story provided at the end of the
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list of useful resources and services. The research nurse
will show the first picture of the booklet to the person
with learning disabilities, who should be encouraged to
hold the book and turn the pages at their own pace. De-
pending on the patient’s communication abilities and re-
actions, it is advised that the research nurse will prompt
them to say what is happening, whether this has hap-
pened to them before, and how they feel about it. We
anticipate that it may take up to one hour to go through
the booklet. If the intervention cannot be explored in
one sitting, the research nurse will arrange a further ap-
pointment. The patient will also be given a copy to take
home and explore with the carer and/or relatives.
It is recommended that the patient is given the oppor-
tunity to use the book at least twice more at home over
the study duration. The research nurse will call each
carer two weeks after randomization to remind them
that the patient should be given opportunities to use the
booklet at least twice more. Use of the book at home
with the carer or other relatives will be monitored as
part of the follow-up assessments. The carers will not re-
ceive any formal training in using the booklet, but will
be able to watch an online video and training slides
explaining how to use the book with the person they
care for. A link to the training video and slides will be
provided by the nurse at the end of the initial meeting.
The research nurse will receive a half-day training
course in using the intervention.
Control group
Participants in the control group will receive routine in-
formation and services. The use of a picture book, such
as the Books Beyond Words intervention or other edu-
cational package, will not be part of the routine consult-
ation. After the study has terminated, patients in the
control condition will be provided with a Books Beyond
Words booklet to use with the epilepsy nurse specialist,
the consultant and/or the carer.
Outcome measures
Each patient will be assessed at baseline (T0), and at four
(T1), 12 (T2) and 20 (T3) weeks after randomization (see
Figure 2.). We will measure the following outcomes for
both groups except where specified otherwise (see
Table 1).
Quantitative assessment
The quantitative assessment will examine the following:
1. Number of eligible patients identified and number
recruited.
2. Variability of the primary outcome quality of life,
using the Epilepsy and Learning Disabilities Qualityof Life (ELDQOL) scale [29,30]. The ELDQOL
consists of four subscales: behaviour, seizure
severity, mood and side effects.
3. Seizure control as a secondary outcome measure,
assessed using a seizure diary.
4. Seizure severity as a secondary outcome measure,
assessed using the seizure severity subscale of the
ELDQOL scale.
5. Discontinuation rates across both arms and
reasons.
6. Patterns of use of the Books Beyond Words booklet
(for intervention group only).
7. Use of other epilepsy-related information.
8. Resource use and health-related quality of life using
a context-specific resource use questionnaire and the
EQ-5D-5 L scale [31].
9. Demographic data: age, sex, ethnicity, and living
circumstances of the participant, information about
the type of care provided by the carer and
relationship to the participant.
Qualitative assessment
We will conduct semi-structured qualitative interviews
at 20 weeks post-randomization, with a random sample
of 15 patients and carers (or until data saturation), se-
lected from both control and intervention groups, as
well as all health professionals involved in the feasibility
trial (n = 9). The semi-structured interviews will explore
the feasibility and acceptability of the recruitment proce-
dures (such as allocation, randomization and potential
weaknesses of the design), use and perceived usefulness
of existing resources and services, information and self-
management support needs, perceived acceptability of
the intervention and perceived barriers and facilitators
to the use and dissemination of the intervention in rou-
tine care.
Data collection and management
Data will be collected at baseline, four, 12 and 20 weeks
post-randomization using a questionnaire and seizure
diary completed by the carer, with the patient’s involve-
ment whenever possible. The baseline questionnaire will
be completed at the initial meeting with the research
nurse. The follow-up questionnaires will be sent to the
carer in the post and returned in a prepaid envelope. A
research fellow will follow-up on patients and carers
using the telephone at four, 12 and 20 weeks post-
randomization to encourage the return of the question-
naires. A random sample of participants will also be
invited to take part in an interview at 20 weeks post-
randomization.
Data management will be provided by NRTU. The web-
based data entry system will be built using Microsoft
SQL Server tools. It will comply with the International
Figure 2 Consolidated Standards of Reporting Trials (CONSORT) study flow-chart.
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for Registration of Pharmaceuticals for Human Use
Guideline for Good Clinical Practice (GCP), and will
be restricted to authorized study team members and
NRTU staff.
Data analysis
Quantitative data
The analysis primarily aims to determine the feasibility
of undertaking a full-scale randomized controlled trial
and will seek to assess:
1. The number and demographics of eligible patients
identified, screened, consented and randomized to
each arm, and the relative performance in each
clinic.
2. The demographics of patients who are excluded
from the trial, reasons for exclusion and
estimation of the proportion of eligible patients
approached who agree to enter and complete the
trial.3. The proportion of completed study measures in
each arm, measured from baseline to the last
follow-up assessment.
4. The proportion of patients withdrawing from the
study, measured from baseline to the last follow-up
assessment.
5. The variation in the primary outcome measure that
will be used, following Cocks and Torgerson [32], to
determine whether a one-sided 80% confidence
interval would exclude a 10% increase in the primary
outcome (ELDQOL).
6. The frequency of use of the Books Beyond Words
intervention, and other sources of information
before and after randomization, and the extent to
which use of the Books Beyond Words booklet
influences outcome and other information
resource use.
In parallel, a health economic assessment will be un-
dertaken. We will monitor levels of resource-use and
quality of life to inform the decision as to how costs and
Table 1 Study procedures according to study schedule
Study procedures Study period
Enrollment Randomization Post-randomization
T0 T1 week 4 T2 week 12 T3 week 20
Eligibility screen X
Informed consent X
Allocation X
Intervention X
Rates of recruitment X X X X
Quality of life (Epilepsy and Learning Disabilities Quality of Life,
ELDQOL. scale)
X X X X
Demographic data X
Seizure severity (using ELDQOL Seizure Severity Scale) X
Seizure control (diary cards) X X X X
Feasibility and acceptability (qualitative interviews) X
Resource use X X
Quality of life (EQ-5D-5L scale) X X X X
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definitive study. NICE guidance recommends that costs
are calculated from the perspective of the NHS and Per-
sonal Social Services (PSS) [33]. We will thereby seek to
monitor levels of resource-use associated with the epi-
lepsy booklet and the use of other NHS and PSS
resource-items. Appropriate unit costs will subsequently
be attached to all items of resource-use, to estimate the
mean overall cost in each study-arm [34]. In line with
NICE guidance, the EQ-5D [35] will be used to assess
the effectiveness of each option. This will enable the
quality-adjusted life year gain to be estimated. All ana-
lyses will be reported according to relevant CONSORT
standards [36].
Qualitative data
The data collected in the semi-structured interviews will
be analyzed using a two-step thematic content analysis
derived from descriptive phenomenology [37,38], assisted
by the computer software NVivo.
Sample size and feasibility of recruitment
The present study aims to assess the variation in the pri-
mary outcome measure between groups from baseline to
the 12-week follow-up assessment, in order to determine
whether the intervention is likely to achieve a 10% in-
crease in the participants’ quality of life [32]. This would
equate to an effect size of approximately 0.4, requiring a
total sample size of 174 in a full study (1-β = 0.8, α =
0.05). Based on the requirement of 9% of the total sam-
ple size in each group, this indicates a required sample
size of 16 per group, and will enable the exclusion of an
effect size of <0. Given a potential 25% dropout rate, a
sample size of 20 per group (40 participants in total) willbe targeted. However, the study team, the selected study
design and recruitment procedures will aim to minimize
all potential dropouts whenever possible.
Recent audit data indicates that there were 196 patients
with epilepsy and learning disabilities registered at the
Hertfordshire Partnership University NHS Foundation
Trust in May 2013. A preliminary screening exercise has
already been undertaken by the lead consultant psych-
iatrist, at each epilepsy clinic, confirming that 112 out of
196 patients meet the study’s inclusion criteria. This does
not include new referrals, who will be screened for eligibil-
ity once recruitment commences. The study will therefore
aim to recruit approximately 36% of eligible patients.
Confidentiality
This study will be conducted in accordance with the
Data Protection Act 1998 [39] and the guidelines of the
Declaration of Helsinki 1964 (updated Tokyo 2004) [40].
Access to the screening and randomization log, contain-
ing patient-identifiable data, will be restricted to autho-
rized personnel and will be password-protected. Only
GCP certified investigators approved by the Trial Steer-
ing Committee will be able to access the data. A unique
patient identification number will be generated by the
study web-based data entry system for each new patient
entered in the system by the research nurse. This en-
sures anonymized data. A sequential number, starting at
001, will be generated for each new patient consented
and entered into the study by the research nurse.
The original signed consent forms will be retained at
the study site, in a locked cabinet. After all participants
have been recruited, the researcher will collect baseline
questionnaires from the epilepsy clinics. All case report
forms and signed consent forms will be collected at the
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University of Hertfordshire. Patient data relating to the
study will be deleted or destroyed within three months
of the end of the study. Anonymized study data will be
archived by the University of Hertfordshire for five years
after study completion, in line with standard research
protocols. Investigators will not disclose patient data in
any form to anyone not involved directly in the study.
All electronic data will be stored on password-protected
computers, and paper files will be stored in locked filing
cabinets, both of which will be kept within electronically
locked offices.
Ethical considerations
This study includes people with learning disabilities who
may or may not lack the capacity to consent. Whenever
possible, consent will be obtained from the patient, with
the carer’s involvement and advice, who will assess the
participants’ capacity to take part, as required by the
Mental Capacity Act. For patients who have the capacity
to read or be read to and understand simple information
(as determined by the carer and research nurse), an
easy-read information sheet and invitation letter will be
provided. These have been specifically designed accord-
ing to the principles of the Mental Capacity Act (2005)
[27], guidance from the Department of Health on produ-
cing easy-read information and guidance from the Na-
tional Ethics Service on the design of study materials for
adults without capacity. The information is paced, care-
fully structured, using simple language and images and
with frequent references made to the carer. The easy-
read consent form, invitation letter and information
sheet have been reviewed by people from Hertfordshire
Partnership University Foundation Trust, specializing in
the development of easy-read information, and by mem-
bers of our reference group, including people with learn-
ing disabilities, carers and members of the public. For
patients who lack the capacity to consent, carers will be
asked to complete and sign a consultee declaration form.
Ethical approval for this study was granted on 28 April
2014, by the Wales Research Ethics Committee 5 (refer-
ence: 14/WA/0135).
Discussion
This study is the first to assess the feasibility of under-
taking a randomized controlled trial of an image-centric
intervention, designed to facilitate the management of
epilepsy in people with learning disabilities. The outputs
of this feasibility study will be used to inform the design
and methodology of a definitive study, adequately pow-
ered to determine the impact of the Books Beyond
Words intervention to improve the management of epi-
lepsy in people with learning disabilities. As advocated
by NICE, The Royal College of General Practitioners andthe Learning Disabilities Observatory, improving disease
management and access to services of people with learn-
ing disabilities and epilepsy is essential and should
become a priority in routine care. Although the feasibil-
ity study will not demonstrate whether or not Books Be-
yond Words interventions can achieve those goals, and
provide value for money, this will be addressed by the
definitive trial. The results will therefore have significant
and long-lasting implications for clinical practice and
service delivery, whereby Books Beyond Words interven-
tions could become routinely embedded in the NHS,
yielding significant benefits for patients, their carers and
the wider population.
Further, the results of the feasibility trial will be of
utmost importance to patient groups and clinicians in
raising awareness of emerging research in learning dis-
abilities and epilepsy, and demonstrating the potential
acceptability of this intervention. Dissemination of the
results will primarily be achieved through publication in
peer-reviewed scientific journals, and reports intended
for people with learning disability, their carers, families
and the wider lay community, disseminated through na-
tional and local patient networks, including the Making
it Better Group, Inclusion East, and the British Institute
of Learning Disabilities (BILD). Promoting the involve-
ment of people with learning disabilities in research and
demonstrating potential benefits will be another focus of
our dissemination strategy. We will work closely with
the BILD and with the Patient Involvement in Research
Group to raise awareness and increase the representa-
tion of patients with learning disabilities and their carers
in research.
Trial status
The trial set-up phase was completed at the end of May
2014. Recruitment started on 1 July 2014 and is ex-
pected to end in March 2015.
Abbreviations
BILD: British Institute of Learning Disabilities; CONSORT: Consolidated
Standards of Reporting Trials; CTU: Clinical Trials Unit; ELDQOL: Epilepsy and
Learning Disabilities Quality of Life (scale); GCP: Good Clinical Practice;
ISRCTN: International Standard Randomized Controlled Trial Number;
NHS: National Health Service; NICE: National Institute for health and Clinical
Excellence; NCTU: Norwich Clinical Trials Unit; PSS: Personal Social Services;
SQL: Structured Query Language; WIELD: Wordless Intervention for Epilepsy
in Learning Disabilities.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
M-A D, BG, GP, AZ, KF, GB, HR, and DW participated in the design and
conception of the study. M-A D, BG and LO drafted the study protocol. All
authors commented on all subsequent drafts of the protocol. M-A D and LO
prepared all study documents and ethics application. M-A D completed the
first draft of the manuscript. All authors commented on all subsequent drafts
of the manuscript. All authors read and approved the final version of the
manuscript.
Durand et al. Trials 2014, 15:455 Page 9 of 9
http://www.trialsjournal.com/content/15/1/455Acknowledgements
The study team are grateful for the continued support and valuable
contributions of the Patient Involvement in Research Group at the University
of Hertfordshire, The Making Better Services Group, Inclusion East, the East of
England Research Design Service, The Norwich Clinical Trials Unit, Books
Beyond Words, and Professor Tim Gale at Hertfordshire Partnership University
NHS Foundation Trust.
This study is funded by the NIHR Research for Patient Benefit program
(reference number: RfPB PB-PG-0213-30042).
Author details
1Centre for Lifespan and Chronic Illness Research, Department of Psychology,
School of Life and Medical Sciences, University of Hertfordshire, College Lane
Campus, Hatfield AL10 9AB, UK. 2The Dartmouth Institute for Health Policy
and Clinical Practice, 37 Dewey Field Road, Hanover, NH 03755, USA.
3University of West London, Institute for Practice, Interdisciplinary Research
and Enterprise (INSPIRE), A410, St Mary’s Road, Ealing, London W5 5RF, UK.
4Hertfordshire Partnership University NHS Foundation Trust, 99 Waverley Rd,
St Albans, Hertfordshire AL3 5TL, UK. 5Norwich Medical School and Norwich
Clinical Trials Unit, Faculty of Medicine and Health Sciences, Chancellor's
Drive, University of East Anglia, Norwich NR4 7TJ, UK. 6Department of
Psychiatry, University of Cambridge School of Clinical Medicine, Box 189
Cambridge Biomedical Campus, Cambridge CB2 2QQ, UK.
Received: 2 June 2014 Accepted: 31 October 2014
Published: 20 November 2014
References
1. Mariani E, Ferini-Strambi L, Sala M, Erminio C, Smirne S: Epilepsy in
institutionalized patients with encephalopathy: clinical aspects and
nosological considerations. Am J Ment Retard 1993, 98(Suppl):27–33.
2. Van Schrojenstein Lantman De Valk HM, Metsemakers JF, Haveman MJ,
Crebolder HF: Health problems in people with intellectual disability in
general practice: a comparative study. Fam Pract 2000, 17:405–407.
3. Van Schrojenstein Lantman De Valk HM, Van Den Akker M, Maaskant MA,
Haveman MJ, Urlings HF, Kessels AG, Crebolder HF: Prevalence and
incidence of health problems in people with intellectual disability.
J Intellect Disabil Res 1997, 41:42–51.
4. Van Schrojenstein Lantman De Valk HM, Walsh PN: Managing health
problems in people with intellectual disabilities. BMJ 2008, 337:a2507.
5. Bowley C, Kerr M: Epilepsy and intellectual disability. J Intellect Disabil Res
2000, 44:529–543.
6. McDermott S, Moran R, Platt T, Wood H, Isaac T, Dasari S: Prevalence of
epilepsy in adults with mental retardation and related disabilities in
primary care. Am J Ment Retard 2005, 110:48–56.
7. McGrother CW, Bhaumik S, Thorp CF, Hauck A, Branford D, Watson JM:
Epilepsy in adults with intellectual disabilities: prevalence, associations
and service implications. Seizure 2006, 15:376–386.
8. Morgan CL, Baxter H, Kerr MP: Prevalence of epilepsy and associated
health service utilization and mortality among patients with intellectual
disability. Am J Ment Retard 2003, 108:293–300.
9. Chadwick D: Epilepsy. J Neurol Neurosurg Psychiatry 1994, 57:264–277.
10. World Health Organization: Epilepsy. [http://www.who.int/mediacentre/
factsheets/fs999/en/]
11. Beavis J, Kerr M, Marson AG: Pharmacological interventions for epilepsy in
people with intellectual disabilities. Cochrane Database Syst Rev 2007,
3, CD005399.
12. Branford D, Bhaumik S, Duncan F: Epilepsy in adults with learning
disabilities. Seizure 1998, 7:473–477.
13. Branford D, Bhaumik S, Duncan F, Collacott RA: A follow-up study of adults
with learning disabilities and epilepsy. Seizure 1998, 7:469–472.
14. Kerr M: Epilepsy and learning disabilities. In Epilepsy: From Cell to
Community, a Practical Guide to Epilepsy. 11th edition. London: Pat Talbot,
Geoff Astbury, Tom Mason, SAGE Publications; 2007.
15. Brodie MJ: Antiepileptic drugs, clinical trials, and the marketplace. Lancet
1996, 347:777–779.
16. Hannah JA, Brodie MJ: Epilepsy and learning disabilities–a challenge for
the next millennium? Seizure 1998, 7:3–13.
17. International Association of the Scientific Study of Intellectual Disabilities
(IASSID): Clinical guidelines for the management of epilepsy in adults
with an intellectual disability. Seizure 2001, 10:401–409.18. Kerr M, Bowley C: Multidisciplinary and multiagency contributions to care
for those with learning disability who have epilepsy. Epilepsia 2001,
42(Suppl 1):55–56. discussion 57–58.
19. Kerr M, Bowley C: Evidence-based prescribing in adults with learning
disability and epilepsy. Epilepsia 2001, 42(Suppl 1):44–45. discussion 50–41.
20. van Blarikom W, Tan IY, Aldenkamp AP, van Gennep ATG: Epilepsy,
intellectual disability, and living environment: a critical review. Epilepsy
Behav 2006, 9:14–18.
21. Glover G, Ayub M: How People With Learning Disabilities Die. Durham:
Improving Health and Lives: Learning Disabilities Observatory; 2010.
22. Cockerell OC, Hart YM, Sander JW, Shorvon SD: The cost of epilepsy in
the United Kingdom: an estimation based on the results of two
population-based studies. Epilepsy Res 1994, 18:249–260.
23. Pennington M, Prince E, Bateman N, Gray J, Croudace TJ, Redley M, Wood
N, Ring H: Factors influencing the costs of epilepsy in adults with an
intellectual disability. Seizure 2012, 21:205–210.
24. Improving Health and Lives: Learning Disabilities Observatory: Improving the
health and wellbeing of people with learning disabilities: an evidence-based
commissioning guide for clinical commissioning groups (CCGs). Durham:
Improving Health and Lives: Learning Disabilities Observatory; 2012.
25. Emerson E, Baines S: Health Inequalities and People with Learning Disabilities.
Durham: Improving Health and Lives: Learning Disabilities Observatory; 2010.
26. National Institute for Health and Care Excellence: The Epilepsies: The
Diagnosis and Management of the Epilepsies in Adults and Children in Primary
and Secondary Care. NICE Clinical Guideline 137. London: NICE; 2012.
27. Mental Capacity Act 2005. [http://www.legislation.gov.uk/ukpga/2005/9/
contents]
28. Books Beyond Words [http://www.booksbeyondwords.co.uk/]
29. Baker GA, Jacoby A, Smith DF, Dewey ME, Chadwick DW: Development of
a novel scale to assess life fulfillment as part of the further refinement of
a quality-of-life model for epilepsy. Epilepsia 1994, 35:591–596.
30. Buck D, Smith M, Appleton R, Baker GA, Jacoby A: The development and
validation of the epilepsy and learning disabilities quality of life
(ELDQOL) scale. Epilepsy Behav 2007, 10:38–43.
31. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia
X: Development and preliminary testing of the new five-level version of
EQ-5D (EQ-5D-5 L). Qual Life Res 2011, 20:1727–1736.
32. Cocks K, Torgerson DJ: Sample size calculations for pilot randomized
trials: a confidence interval approach. J Clin Epidemiol 2013, 66:197–201.
33. National Institute for Clinical Excellence: NICE Guide to the Methods of
Technology Appraisal. London: NICE; 2008.
34. Curtis L: Unit Costs of Health and Social Care 2011. The University of Kent:
Personal Social Services Research Unit; 2011.
35. Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53–72.
36. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated
guidelines for reporting parallel group randomized trials. BMJ 2010,
340:c332.
37. Denzin NK, Lincoln YS: Handbook of Qualitative Research. 2nd edition.
Thousand Oaks: Sage Publications; 2000.
38. Holloway I: Qualitative Research in Health Care. Maidenhead: Open University
Press; 2005.
39. Data Protection Act 1998 [http://www.legislation.gov.uk/ukpga/1998/29/
contents]
40. World Medical Association: WMA Declaration of Helsinki. Ethical Principles for
Medical Research Involving Human Subjects, Amended by the 59th WMA
General Assembly, Seoul, Korea, 2008. Ferney-Voltaire, France: WMA; 2008.
doi:10.1186/1745-6215-15-455
Cite this article as: Durand et al.: Wordless intervention for epilepsy in
learning disabilities (WIELD): study protocol for a randomized controlled
feasibility trial. Trials 2014 15:455.
